-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Iovance Biotherapeutics, Raises Price Target to $11

Benzinga·08/18/2026 11:57:36
Listen to the news
Mizuho analyst Mara Goldstein maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Outperform and raises the price target from $10 to $11.